ReviewChemical Society reviews2024
Application of first-row transition metal complexes bearing 1,2,3-triazolylidene ligands in catalysis and beyond.
Review in Chemical Society reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Alkyne insertion at a nickel-aluminum heterometallic complex: implications for pyridine alkenylation.Chemical science · 2026Article
- Stable in Four Oxidation States: Exploring the Redox-Variability of Molybdenum and Tungsten Triazolylidene Complexes.Inorganic chemistry · 2026Article
- Methylene-Linked Triazolylidenes as Cooperative Ligands in Manganese-CatalyzedInorganic chemistry · 2026Article
- Cobalt-based metallo-mesoionic carbene gold complexes with antiproliferative effects.Dalton transactions (Cambridge, England : 2003) · 2026Article
- An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Metal-based triazoles as a medical marvel of the modern era: a comprehensive review.RSC advances · 2026Review
- High-throughput triazole-based combinatorial click chemistry for the synthesis and identification of functional metal complexes.Nature communications · 2025Article
- Bimolecular Homolytic Substitution (SACS central science · 2025Review
- Synthesis and electrochemical properties of molybdenum nitrido complexes supported by redox-active NHC and MIC ligands.Dalton transactions (Cambridge, England : 2003) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Triazole-derived N-heterocyclic carbenes, triazolylidenes (trz) have become an interesting alternative to the ubiquitous Arduengo-type imidazole-derived carbenes, in part because they are stronger donors, and in other parts due to their versatile synthesis through different types of click reactions. While the use of trz ligands has initially focused on their coordination to precious metals for catalytic applications, the recent past has seen a growing interest in their impact on first-row transition metals. Coordination of trz ligands to such 3d metals is more challenging due to the orbital mismatch between the carbene and the 3d metal center, which also affects the stability of such complexes. Here we summarize the strategies that have been employed so far to overcome these challenges and to prepare first-row transition metal complexes containing at least one trz ligand. Both properties and reactivities of these trz complexes are comprehensively compiled, with a focus on photophysical properties and, in particular, on the application of these complexes in homogeneous catalysis. The diversity of catalytic transformations entailed with these trz 3d metal complexes as well as the record-high performance in some of the reactions underpins the benefits imparted by trz ligands.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.